Exposed Full Movie 2016

[Edilma Howard]

Withthis solicitation, OJJDP seeks to provide funding to communities to develop coordinated and comprehensive community-based approaches to help children and their families who are exposed to violence build resilience, restore their safety, heal their social and emotional wounds, and prevent future violence and delinquency. Funding can be used to develop and/or enhance support services for children exposed to violence to reduce the adverse impact of violence on youth, families, and communities, and to help family-serving organizations better recognize and help families at risk for exposure to violence.

This program focuses on building protective factors for children exposed to violence; increasing access to and providing evidence-based, culturally specific, trauma-informed specialized services/intervention(s) to support children and families who are impacted; as well as the sustainment of this work.

Eligibility

This solicitation is composed of two grant categories. Applicants must clearly designate the category for which they are applying. The following entities are eligible to apply:

Category 1: Project Sites

Hi @AndrewY, the Vault Health Reports in the Bitwarden Web Vault includes an Exposed Passwords Report which can identify passwords that have been uncovered in known data breaches that were released publicly or sold on the dark web by hackers.

Your password probably matches by coincidence. The exposed password report does not state that YOUR use of the password was the source of the leak - it could have been the credentials of someone else that leaked and your password just happens to be identical. This is very common with weak passwords.

This guidance is intended for people who have had mpox exposures in the community. Guidance for exposures in healthcare settings can be found here: Infection Prevention and Control of Mpox in Healthcare Settings.

Anyone with an exposure to people or animals with mpox should monitor their health or be monitored for signs or symptoms consistent with mpox for 21 days after their last exposure. Information about human-to-human transmission of monkeypox virus is described in How it Spreads Mpox Poxvirus CDC.

Monitoring should include assessing the person for signs and symptoms of mpox, including a thorough skin and mouth (oral) exam in good lighting. Skin examination can be performed by the person in isolation, a caregiver, or a healthcare provider and should include examination of the genitals and anus for rash or lesions.

To date, there have been no cases of mpox transmitted by blood transfusion, organ transplantation, or implantation, transplantation, infusion, or transfer of human cells, tissues, or cellular or tissue-based products (HCT/Ps). As a precaution, patients with exposures should not donate blood, cells, tissue, breast milk, or semen while they are being monitored for symptoms. Given the morbidity and mortality among individuals awaiting organ transplantation, persons who have been exposed, but who are asymptomatic and without evidence of monkeypox virus infection, could be considered for organ donation following appropriate risk-benefit considerations.

Some people may be unable to communicate onset of symptoms, such as newborns, young children, or people with cognitive disorders. Parents and other caregivers should watch for changes in behavior and temperament that could signal that the person is experiencing uncomfortable symptoms such as fatigue or headache.

Each risk level category in the table below is intended to highlight the need for monitoring and assist with determining the need for postexposure prophylaxis (PEP). The exposure risk level of any incident may be recategorized to another risk level at the discretion of the treating clinician or public health authorities due to the unique circumstances of each exposure incident.

Mpox typically spreads through prolonged close, skin-to-skin contact with a person who has mpox, or their contaminated materials (e.g., clothing, bed sheets). Transmission during quick interactions (e.g., brief conversation), between people in close proximity has not been reported for any persons with mpox.

There may be settings in which contact tracing is not feasible due to the characteristics of the setting (e.g., level of crowding, types of interactions occurring). In settings where contact tracing is not feasible, people who spent time in the same area as someone with mpox should be considered to have intermediate or lower degree of exposure.

Factors that may increase the risk of mpox transmission include (but are not limited to): the person with mpox had clothes that were soiled with bodily fluids or secretions (e.g., discharge, skin lesion crusts or scabs on clothes) or was coughing while not wearing a mask or respirator, or the exposed individual is not previously vaccinated against smallpox or mpox. People who may be at increased risk for severe disease include (but are not limited to): young children (

Respiratory viruses like COVID-19, influenza (flu), and RSV can cause a range of symptoms, including but not limited to cough, fever, chills, headache, sore throat, runny or stuffy nose, sneezing, chest discomfort, decrease in appetite, vomiting, diarrhea, fatigue (tiredness), muscle or body aches, new loss of taste or smell, weakness, and wheezing. If you are sick or test positive for a respiratory virus, it is important to take steps to help prevent the spread of the virus to others in your home and community and to reduce your likelihood of getting very sick. Stay home and away from others, get tested if accessible, and get treatment if you are eligible.

This page describes what to do if you are sick with COVID-19 or another respiratory virus, as well as what to do if you were exposed to COVID-19 or another respiratory virus. Some guidance on this page is just for COVID-19. This guidance provides baseline recommendations. Please also follow any local health jurisdiction, workplace, business, or school policies, which may provide additional guidance specific to their setting or community. Employers must follow Washington State Department of Labor & Industries (L&I) COVID-19 requirements in the workplace: L&I Requirements and Guidance for Preventing COVID-19.

This guidance does not apply to health care settings but may be followed by residential care settings except when health care services are being provided. People who are working, staying, or visiting in health care settings, including long-term care settings, should follow the guidance in COVID-19 Infection Prevention in Health Care Settings. Flu guidance for health care settings, including skilled nursing facilities can be found on the CDC's Prevention Strategies for Seasonal Influenza in Healthcare Settings webpage. Long-term care settings include skilled nursing facilities and residential care settings such as adult family homes, assisted living facilities, supported living, and enhanced services facilities.

If you have respiratory virus symptoms that are not better explained by another cause (such as allergies) or test positive for COVID-19 or another respiratory virus, follow CDC guidance for staying home and away from others; this includes people you live with who are not sick.

You can tell your symptoms are improving when you start to feel better and you feel well enough to fully participate in your activities, such as learning in a classroom or completing tasks at work. A respiratory virus infection can have many types of symptoms, some of which can last beyond when someone is contagious (able to spread the virus), such as a lingering cough. Having a single symptom or a combination of symptoms is not as important as the overall sense of feeling better and the ability to resume activities.

When you go back to your normal activities, wear a mask and take added precautions over the next 5 days, such as taking steps to improve air flow and filtration, practicing good hand hygiene, cleaning regularly, physical distancing, and testing when you will be around other people indoors. You may still be contagious with a respiratory virus after returning to your normal activities, so it is important to take additional precautions.

If there is an outbreak in a setting such as a workplace or congregate housing, it may be necessary to isolate for a specific period of time longer than you would otherwise to help stop the spread of COVID-19 or another respiratory virus. If you have questions about responding to an outbreak, reach out to your local health jurisdiction for more information.

If you are sick, there are additional precautions you can take to prevent spreading COVID-19 to people at high risk of getting very sick, such as older adults and people with weakened immune systems. Consider staying away from people at high risk of getting very sick until:

If you need to be around someone at high risk of getting very sick during this time, the most protective step you can take is wearing a well-fitting mask when around them. You can also take steps to improve air flow and filtration, physically distance, clean regularly, and practice good hand hygiene.

If you have respiratory virus symptoms that are not better explained by another cause (such as allergies), get tested for COVID-19 if accessible. Testing is especially important if you are at high risk of getting very sick or if you are likely to have close contact with someone else who is at high risk of getting very sick. Testing can help you determine what is causing your symptoms so you can get effective treatment, if eligible. You can use at-home tests for COVID-19, and providers can test you for COVID-19, flu, and other respiratory viruses if needed. If you are at high risk and test positive for COVID-19, or if you are at high risk and have flu symptoms, talk to your health care provider right away to determine if you are eligible for treatment, even if your symptoms are mild right now. Medications to treat COVID-19 and flu must be prescribed by a health care provider and started as soon as possible after diagnosis. For more information about treatment, visit the DOH COVID-19 Treatments webpage and the CDC Flu Treatment webpage.

3a8082e126